Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

24.40 -0.48 (-1.93%)
Official Closing Price Updated: 7:00 PM EST, Nov 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Should You Forget Pfizer and Buy This Magnificent Drug Stock Instead? ↗
Pfizer has a huge dividend yield and a high payout ratio compared to Merck, which could make Merck the more attractive dividend stock. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Viking Therapeutics Stock Soars To 10-Month High After Canaccord Boost – Retail Traders See It As Next Big Obesity Play ↗
Canaccord said Viking’s obesity pipeline is worth far more than the current valuation. 
Via Stocktwits
News headline image
Reflecting On Generic Pharmaceuticals Stocks’ Q3 Earnings: Viatris (NASDAQ:VTRS)
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the generic pharmaceuticals stocks, including Viatris (NASDAQ:VTRS) and its peers. 
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
3 Healthcare Stocks Topping a 2025 List of Dividend Yields ↗
Turn health into wealth with these three high-yielding dividend stocks. 
Via The Motley Fool
News headline image
Curious about the most active S&P500 stocks in today's session? ↗
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the most active S&P500 stocks in today's session. 
Via Chartmill
News headline image
Dow Soars to New Record High as Government Shutdown Nears End
New York, NY – November 12, 2025 – The Dow Jones Industrial Average (DJIA) surged by nearly 400 points today, hitting an unprecedented record high, as investors enthusiastically embraced the impending... 
Via MarketMinute
Topics Economy Government Stocks
News headline image
Looking Into Pfizer Inc's Recent Short Interest ↗
 
Via Benzinga
News headline image
Eledon Pharmaceuticals Stock Plunges Following $50 Million Public Offering
Irvine, CA – November 12, 2025 – Eledon Pharmaceuticals (NASDAQ: ELDN) witnessed a significant decline in its stock value today, plummeting by 17.8% in premarket trading. This sharp drop comes on the... 
Via MarketMinute
Topics Initial Public Offering Intellectual Property Regulatory Compliance
News headline image
2 Strong Healthcare Stock Picks for Value Investors ↗
Value-driven plays abound in the top healthcare stocks. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
From Pfizer Inc.
Via Business Wire
News headline image
Novo Nordisk's $100 Million Coramitug Shows Promise In Reducing Heart Failure Biomarker ↗
Novo Nordisk's Coramitug cut NT-proBNP levels and was well tolerated in a Phase 2 ATTR-CM trial, paving the way for its Phase 3 CLEOPATTRA study. 
Via Benzinga
News headline image
Santa Claus Rally: 3 Discounted Stocks Heading Into 2026 ↗
Pfizer’s comeback, Newmont’s resilience, and Utz’s growth positioning make them compelling candidates for year-end gains. 
Via Talk Markets
News headline image
Why Metsera's Share Price Is Plummeting This Week ↗
The biotech start-up's stock had been rising rapidly in 2025. 
Via The Motley Fool
News headline image
3 Unprofitable Stocks That Concern Us
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital... 
Via StockStory
‘Somebody Knows Something:’ Viking Therapeutics Stock Pops To Nearly 3-Month High As Retail Traders Intensely Speculate On M&A Scenarios ↗
Via Stocktwits
News headline image
1 Large-Cap Stock for Long-Term Investors and 2 We Turn Down
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an... 
Via StockStory
News headline image
Pfizer, Amneal, Jazz Pharmaceuticals, BD, and DaVita Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid... 
Via StockStory
Topics Artificial Intelligence Stocks
News headline image
Novo Nordisk Rises Despite Metsera Loss, Slashes Wegovy Price In India ↗
Novo Nordisk shares are trading higher on Tuesday. The company recently lost its bidding war for Metsera Inc. 
Via Benzinga
News headline image
Most active S&P500 stocks in Tuesday's session ↗
Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention. 
Via Chartmill
News headline image
Curious about the most active stocks on Tuesday? ↗
Discover the most active stocks in Tuesday's session. Stay informed about the stocks that are generating the most trading volume! 
Via Chartmill
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
AI Takes Center Stage: LogiPharma Report Reveals Pharmaceutical Supply Chains Embrace Intelligent Automation
The pharmaceutical industry, long known for its meticulous processes and stringent regulations, is undergoing a profound transformation driven by Artificial Intelligence. A recent LogiPharma AI Report... 
Via TokenRing AI
Topics Artificial Intelligence Economy Fraud
News headline image
Where Will Pfizer Be in 3 Years? ↗
Pfizer is working to deal with typical business issues in the drug space, but its attempt at a solution has become very complicated. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Who's Winning the Intense Battle to Rule the White-Hot GLP-1 Drug Market? ↗
Three large pharmaceutical makers are jockeying for position in the rapidly expanding market for GLP-1 drugs. 
Via The Motley Fool
News headline image
Shutdown Deal Breathes New Life Into Wall Street ↗
The prospect of a quick end to the US government shutdown has rekindled investor confidence. Tech rebounds, semiconductors sprint ahead, and insurers feel political pressure building. Meanwhile, all... 
Via Chartmill
News headline image
Why a Strong Quarter Wasn't Enough to Send Shares of Pfizer Soaring ↗
Pfizer not only beat expectations last quarter, but also boosted its guidance. 
Via The Motley Fool
Topics Earnings Intellectual Property
News headline image
The Top 5 Analyst Questions From Pfizer’s Q3 Earnings Call
Pfizer’s third quarter results reflected ongoing challenges in its COVID-19 franchise, but management pointed to solid growth in non-COVID products and disciplined cost management as key drivers of... 
Via StockStory
Topics Earnings
News headline image
Healthcare Sector Navigates Turbulent Waters: Innovation Surges Amidst Political Headwinds
New York, NY – November 10, 2025 – The S&P 500 Healthcare sector presented a mixed picture today, with the broader index showing a modest uptick while significant segments, particularly health insurers... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
Looking for the most active stocks in the S&P500 index on Monday? ↗
Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention. 
Via Chartmill
News headline image
These stocks are the most active in today's session ↗
Monday's session is buzzing with activity. Check out the stocks that are attracting the most attention and driving market activity! 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.